NObreath®
The NObreath® fractional exhaled nitric oxide test monitor, recommended in the NICE guidance for measuring FeNO concentration in Asthma (DG12).
The NObreath® fractional exhaled nitric oxide test monitor, recommended in the NICE guidance for measuring FeNO concentration in Asthma (DG12). Measuring FeNO with NObreath® FeNO tester allows consistent, non-invasive measurement of expired breath Nitric Oxide (NO). This can be used as a marker for airway inflammation and on-going monitoring of treatment.
fractional exhaled nitric oxide (FeNO) breath testing monitor to measure airway inflammation and improve asthma management.
The NObreath® has been recommended by NICE to measure FeNO and aid in diagnosing asthma, in adults and children, as well as monitoring and managing asthma symptoms of patients.
Why NObreath®?
Using FeNO measurements to evaluate airway inflammation in asthma represents a significant advance in respiratory medicine2, but until now it has been an expensive test to deliver in everyday practice. Recommended by NICE4 and conformed to ERS/ATS guidelines5, the NObreath® FeNO monitor is the essential tool for asthma.
Features and benefits include:
Unlimited FeNO testing*
Low-cost monitor and consumables
Easy-to-use
Reliable and accurate results
Low maintenance
Fully portable and handheld FeNO monitor
Colour touch screen
Adult and child profiles
Ambient NO monitoring